4.8 Article

Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis

Journal

CANCER CELL
Volume 27, Issue 5, Pages 682-697

Publisher

CELL PRESS
DOI: 10.1016/j.ccell.2015.04.003

Keywords

-

Funding

  1. British Columbia Cancer Foundation
  2. Terry Fox Research Institute [1021]
  3. Collaborative Health Research Project grant from the Canadian Institutes of Health Research and Natural Science and Engineering Research Council
  4. Ewings Cancer Foundation of Canada [C17]
  5. Childhood Cancer Canada Foundation
  6. Coast to Coast Against Cancer Foundation
  7. Egyptian government
  8. Beatrice Hunter Cancer Research Institute
  9. Canadian Institutes of Health Research

Ask authors/readers for more resources

Metastatic dissemination is the leading cause of death in cancer patients, which is particularly evident for high-risk sarcomas such as Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma. Previous research identified a crucial role for YB-1 in the epithelial-to-mesenchymal transition (EMT) and metastasis of epithelial malignancies. Based on clinical data and two distinct animal models, we now report that YB-1 is also a major metastatic driver in high-risk sarcomas. Our data establish YB-1 as a critical regulator of hypoxia-inducible factor 1 alpha (HIF1 alpha) expression in sarcoma cells. YB-1 enhances HIF1 alpha protein expression by directly binding to and activating translation of HIF1A messages. This leads to HIF1 alpha-mediated sarcoma cell invasion and enhanced metastatic capacity in vivo, highlighting a translationally regulated YB-1-HIF1 alpha axis in sarcoma metastasis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available